发明授权
- 专利标题: Glioblastoma inhibiting compounds and their use
- 专利标题(中): 成胶质细胞瘤抑制化合物及其用途
-
申请号: US14126512申请日: 2012-06-15
-
公开(公告)号: US09573960B2公开(公告)日: 2017-02-21
- 发明人: Björn Scheffler , Martin Glas , Matthias Simon , Sabine Gogolok , Daniel Trageser , Roman Reinartz , Anja Wieland
- 申请人: Björn Scheffler , Martin Glas , Matthias Simon , Sabine Gogolok , Daniel Trageser , Roman Reinartz , Anja Wieland
- 申请人地址: DE Bonn DE Bonn
- 专利权人: Life & Brain GmbH,Rheinische Friedrich-Wilhelms Universitat
- 当前专利权人: Life & Brain GmbH,Rheinische Friedrich-Wilhelms Universitat
- 当前专利权人地址: DE Bonn DE Bonn
- 代理机构: Barnes & Thornburg LLP
- 国际申请: PCT/EP2012/061485 WO 20120615
- 国际公布: WO2012/172069 WO 20121220
- 主分类号: C07D493/06
- IPC分类号: C07D493/06 ; C07D493/18 ; A61K31/352 ; G01N33/574 ; A61K31/4188
摘要:
The present invention relates to glioblastoma inhibiting compounds, in particular gambogic acid amid and derivatives thereof for the treatment of glioblastoma. Moreover, methods for determining whether a treatment with the compounds of the invention is suitable for a patient are disclosed.
公开/授权文献
- US20150148390A1 GLIOBLASTOMA INHIBITING COMPOUNDS AND THEIR USE 公开/授权日:2015-05-28